Efficacy and safety of poly (γ-glutamic acid) based nanoparticles (γ-PGA NPs) as vaccine carrier

Yakugaku Zasshi

Volumn 128, Issue 11, 2008, Pages 1559-1565

  Nakagawa, Shinsaku ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

glutamic acid (poly); Drug delivery system; Nanoparticle; Vaccine carrier

Indexed keywords

DRUG CARRIER; ESTER DERIVATIVE; FREUND ADJUVANT; GLUTAMIC ACID; NANOPARTICLE; OVALBUMIN; PHENYLALANINE ETHYL ESTER; POLY (GAMMA GLUTAMIC ACID); UNCLASSIFIED DRUG; VACCINE;

DRUG EFFICACY; DRUG SAFETY; IMMUNIZATION; NONHUMAN; REVIEW; T LYMPHOBLAST;

ANIMALS; CANCER VACCINES; DRUG DELIVERY SYSTEMS; DRUG TOXICITY; GLUTAMIC ACID; HUMANS; MICE; NANOPARTICLES;

EID: 56049086196     PISSN: 00316903     EISSN: 13475231     Source Type: Journal    
DOI: 10.1248/yakushi.128.1559     Document Type: Review

References (20)

1. Zhang S., Nat. Biotechnol., 21, 1171-1178 (2003).
2. Hilt J. Z., Adv. Drug Deliv. Rev., 56, 1533-1536 (2004).
3. Rosler A., Vandermeulen G. W., Klok H. A., Adv. Drug Deliv. Rev., 53, 95-108 (2001).
4. Akagi T., Higashi M., Kaneko T., Kida T., Akashi M., Macromol. Biosci., 5, 598-602 (2005).
5. Akagi T., Kaneko T., Kida T., Akashi M., J. Control. Release., 108, 226-236 (2005).
6. Yoshikawa T., Okada N., Oda A., Matsuo K., Matsuo K., Mukai Y., Yoshioka Y., Akagi T., Akashi M., Nakagawa S., Biochem. Biophys. Res. Commun., 366, 408-413 (2008).
7. Yoshikawa T., Okada N., Oda A., Matsuo K., Matsuo K., Kayamuro H., Ishii Y., Yoshinaga T., Akagi T., Akashi M., Nakagawa S., Vaccine, 26, 1303-1313 (2008).
8. Urban J. L., Schreiber H., Annu. Rev. Immunol., 10, 617-644 (1992).
9. Smyth M. J., Godfrey D. I., Trapani J. A., Nat. Immunol., 2, 293-299 (2001).
10. Huang, A. Y., Golumbek P., Ahmadzadeh M., Jaffee E., Pardoll D., Levitsky H. R., Science, 264, 961-965 (1994).
11. Wang F., Bade E., Kuniyoshi C., Spears L., Jeffery G., Marty V., Groshen S., Weber J., Clin. Cancer Res., 5, 2756-2765 (1999).
12. Toes R. E., Blom R. J., Offringa R., Kast W. M., Melief C. J., J. Immunol., 156, 3911-3918 (1996).
13. Singh M., O'Hagan, D. T., Int. J. Parasitol., 33, 469-478 (2003).
14. Singh M., O'Hagan D. T., Pharm Res., 19, 715-728 (2002).
15. Falo Jr. L. D., Kovacsovics-Bankowski M., Thompson K., Rock K. L., Nat. Med., 1, 649-653 (1995).
16. Storni T., Kundig T. M., Senti G., Johansen P., Adv. Drug Deliv. Rev., 57, 333-355 (2005).
17. Steinman R. M., Inaba K., Turley S., Pierre P., Mellman I., Hum. Immunol., 60, 562-567 (1999).
18. Mellman I., Steinman R. M., Cell, 106, 255-258 (2001).
19. Sue D. X., Anja S., Gabriela M., Cassandra D., Vasso A., Patricia L. M., Magdalena P., Methods, 40, 1-9 (2006).
20. Ian D. D., Weisan C., Heather J., Phillip P., Eric W. H., Lloyd J. O., Jonathan S. C., Proc. Natl. Acad. Sci. U.S.A., 101, 10697-10702 (2004).